<- Go Home
SIGA Technologies, Inc.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Market Cap
$594.3M
Volume
720.8K
Cash and Equivalents
$182.5M
EBITDA
$101.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$123.9M
Profit Margin
69.00%
52 Week High
$9.62
52 Week Low
$4.95
Dividend
7.23%
Price / Book Value
2.84
Price / Earnings
7.28
Price / Tangible Book Value
2.85
Enterprise Value
$412.9M
Enterprise Value / EBITDA
4.04
Operating Income
$101.1M
Return on Equity
43.61%
Return on Assets
29.51
Cash and Short Term Investments
$182.5M
Debt
$1.1M
Equity
$209.3M
Revenue
$179.6M
Unlevered FCF
$91.4M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium